<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "inFLIXimab inj VIAL">
<dose><value>5</value>
<value>10</value>
<value>3</value>
</dose>
<route><value>IV</value>
</route>
<strength><value>100 mg</value>
</strength>
<frequency><value>ONCE</value>
</frequency>
<instruction><value>Administer dose intravenously over 2 hours.</value>
</instruction>
<volume></volume>
<units><value>mg/kg</value>
</units>
<Population></Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Crohn&amp;apos;s Disease / Fistulizing Crohn&amp;apos;s Disease: followed by additional doses at 2 and 6 weeks after initial dose, then every 8 weeks thereafter.</value>
<value>Fistulizing Crohn&amp;apos;s Disease in patients no longer responsing to 5 mg/kg treatment.</value>
<value>Rheumatoid Arthritis: followed by additional doses at 2 and 6 weeks after initial dose, then every 8 weeks thereafter.</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3608</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus></AHSFormularyStatus>
<HighAlert></HighAlert>
</drug>